Matches in Nanopublications for { ?s ?p "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP751081.RAltYseZwePxXyslb1j8ZeB506KV8cIj0ONmmr_nFKbvQ130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751081.RAltYseZwePxXyslb1j8ZeB506KV8cIj0ONmmr_nFKbvQ130_provenance.
- assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP424321.RAcbgtFZ4ifkdjhYZGQY5PeqT_x8O5phE0iBdOmjztTwc130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424321.RAcbgtFZ4ifkdjhYZGQY5PeqT_x8O5phE0iBdOmjztTwc130_provenance.
- NP783244.RALNwYpl__8Rjha6JttSueE5ejKAEUFTFSYHv-VzGXSYg130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783244.RALNwYpl__8Rjha6JttSueE5ejKAEUFTFSYHv-VzGXSYg130_provenance.
- NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424287.RApQzV0T9iBrBL0HxkjR3EwMnlk84mkTgXvcffDPKapms130_provenance.
- NP756336.RAiAylmrLYLuPNlZ2rBw1z_DO97eXZSrN-DyvDEI7Tv24130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756336.RAiAylmrLYLuPNlZ2rBw1z_DO97eXZSrN-DyvDEI7Tv24130_provenance.
- NP424097.RAxQ6lGil5_dKWClHQlIuoOwsXKCEDsTwdMtJA_cfp3jg130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424097.RAxQ6lGil5_dKWClHQlIuoOwsXKCEDsTwdMtJA_cfp3jg130_provenance.
- NP756338.RA8Ex7WuVmY1E9HXVUpvSB94-LvRiNDDPy7_XO42VxivQ130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756338.RA8Ex7WuVmY1E9HXVUpvSB94-LvRiNDDPy7_XO42VxivQ130_provenance.
- NP756339.RA-MTHTP8PbT3yQ8bcm0VQWcyTiM_p50HHIrlHxui0r2Y130_assertion description "[2) There was no statistical difference in the prevalence of scoliosis between the GH treatment group (32.8%) and the GH nontreatment group (group with no GH treatments) (46.5%) (p=.16, chi-square test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756339.RA-MTHTP8PbT3yQ8bcm0VQWcyTiM_p50HHIrlHxui0r2Y130_provenance.